Regulatory News:
Cellectis SA (Alternext:ALCLS) publishes its consolidated financial statements for 2014, as approved by the Board of Directors at their meeting on March 3, 2015.
•Total revenues and other income amounted to €26.4 M. This is mainly due to the collaboration agreements signed with Servier and Pfizer.
Help employers find you! Check out all the jobs and post your resume.
